NKY(SZ:300109) Xin Lang Zheng Quan·2025-09-19 05:47Company Overview - Xin Kai Yuan Medical Technology Group Co., Ltd. is located in Jiaozuo City, Henan Province, established on March 13, 2003, and listed on August 25, 2010. The company specializes in the R&D, production, and sales of PVP series products, PVME/MA high-value pharmaceutical excipients, and functional high polymer materials, as well as in vitro diagnostic services including early cancer diagnosis, molecular diagnostics, and gene sequencing [1][2]. Financial Performance - As of September 10, 2023, Xin Kai Yuan reported a revenue of 644 million yuan for the first half of 2025, a year-on-year decrease of 12.36%. The net profit attributable to the parent company was 139 million yuan, down 34.74% year-on-year [2]. - The company has cumulatively distributed 900 million yuan in dividends since its A-share listing, with 607 million yuan distributed over the past three years [3]. Stock Performance - On September 19, 2023, Xin Kai Yuan's stock price increased by 2.10%, reaching 17.49 yuan per share, with a trading volume of 155 million yuan and a turnover rate of 2.02%. The total market capitalization stood at 8.501 billion yuan [1]. - Year-to-date, the stock price has risen by 11.39%, but it has seen a decline of 2.45% over the last five trading days and 5.05% over the last 20 days, while increasing by 8.16% over the last 60 days [1]. Shareholder Information - As of September 10, 2023, the number of shareholders for Xin Kai Yuan was 20,500, a decrease of 6.39% from the previous period. The average number of circulating shares per person increased by 6.83% to 21,942 shares [2]. Business Segments - The main revenue sources for Xin Kai Yuan include: - PVP Others: 39.57% - PVPK30 Powder: 28.35% - Oruisi Series: 14.80% - PVP-I: 6.85% - Precision Medical Services: 3.45% - Early Cancer Diagnosis: 3.08% - Gene Testing Technology: 3.04% - Molecular Diagnostic Services: 0.87% [1]. Industry Classification - Xin Kai Yuan is classified under the Shenwan industry category of Basic Chemicals - Chemical Products - Other Chemical Products, and is associated with concepts such as stem cells, biomedicine, innovative drugs, cancer treatment, and precision medicine [2].